Sabino Investment Management, L.L.C.

 

[back to Newsletter Archive]

Newsletter Q3 1999
July 12, 1999

Do Interest Rates Matter?

The recent rise in interest rates has not had much effect on the stock market.  On June 30, the Federal Reserve raised interest rates by 25 basis points.  Stock investors instead focused on the Fed's statement regarding a change in bias from tightening to neutral, and stocks subsequently rallied.  Corporate borrowers, on the other hand, appear eager to sell debt as the supply of corporate bond issues is expected to be plentiful in coming months.

The valuation model that I use for a comparison of the S&P 500 to the ten year U.S. Treasury bond suggests that the S&P 500 is currently overvalued by 29% relative to the ten year U.S. Treasury bond.  Byron Wien, investment strategist at Morgan Stanley Dean Witter, also maintains a quantitative model to compare stocks to bonds.  His model suggests that the S&P 500 is overvalued by 35% relative to bonds.  Accordingly, I have been raising the percentage of cash in portfolios in recent months.

^ back to top 

Updates

Qualcomm's (QCOM) price got another boost recently after President and Chief Operating Officer Richard Sulpizio spent a week in Europe meeting with European investment managers and analysts.  Sometime before the end of November, the International Telecommunications Union is expected to endorse Qualcomm's CDMA as the third generation wireless standard.  Earnings estimates are currently $2.04 per share for FYE 9/30/99 and $2.73 for next year.

The price of the convertible preferred shares of American Real Estate Partners (ACP.PR) has started to rise recently as the potential conversion date approaches.  The preferred shares will be convertible at the option of the company in March 2000 and must be redeemed by the company by March 2010.  Carl Icahn is the general partner and owns 86.5% of the preferred units.  Because it is in his best interest to convert at the earliest possible date, the Partnership will most likely convert the preferred shares to depositary (limited partnership) units in March 2000.  If the Partnership does convert the preferred units in March 2000, the conversion price (10.5 with accrued dividends) represents a 26% gain from last week's close of $8.31.  The depositary units are also undervalued as they currently sell for less than 7X earnings, or less than the value of cash and U.S. Treasury bills held by the Partnership.

The Board of Directors of the Heritage U.S. Government Income Fund (HGA) has proposed that the fund change from a closed-end structure by merging with an affiliated open-end mutual fund.  This is a positive development as the mutual fund's shares will be redeemable at net asset value.  The fund will be sending proxy material to shareholders for approval and the transaction is expected to be completed by the end of October.

Earnings estimates for Omniquip International (OMQP) have recently declined.  The Company's Snorkel Division manufactures elevated platform equipment that accounted for 26% of sales during the March quarter.  The Snorkel Division was slow to respond to price cuts by competitors earlier in the year but has recently cut prices to reduce inventory.  The company will take a restructuring charge of $2.2 million in the current quarter to reduce the Snorkel workforce by 25% and consequently, consensus earnings estimates have been lowered to $1.21 for the current FYE 9/30/99 and $1.53 for next year.  I continue to own the company, as the current price is a low multiple of the earnings estimates and demand remains strong for the company's other product lines.

Holly Corporation (HOC) has recently moved up a little as concerns about the Longhorn Partners lawsuit subside.  HOC had paid some legal bills for ranchers who had joined the City of Austin and the Lower Colorado River Authority in a lawsuit against Longhorn Partners to require an environmental impact study for a proposed product pipeline from the Gulf Coast to El Paso.  Longhorn Partners has dropped all issues except for tortious interference in its lawsuit against HOC.  In the meantime, product margins look favorable for the summer season and the company is likely to earn in excess of $2.00 per share for the current fiscal year ending in July.

^ back to top

Additions

Borders Group, Inc. (BGP) is the nation's second largest book retailer with 250 Borders superstores and 900 mall-based Waldenbooks stores.  BGP's stock price has declined in the last year from a high of 41.75 to the mid-teens due to concerns about internet competition.  In sharp contrast to Amazon.com, BGP makes money, has virtually no long-term debt, and sells at a reasonable valuation.  Consolidated revenues for the fiscal year ending January 24, 1999 increased by 14.5% over the prior year.  Consensus earnings estimates are $1.17 for the current fiscal year and $1.38 for next year.

Colonial Properties Trust (CLP) is a large diversified REIT in the Southeast that owns 15,000 apartment units, 13.5 million square feet of retail shopping space and 2.7 million square feet of office space.  The dividend yield is currently 8.2% and dividends have grown at an annual rate of six percent during the last five years.

MFC Bancorp (MXBIF) is based in Geneva, Switzerland and provides private and investment banking services.  MXBIF is conservatively financed with an equity/asset ratio of 62.8%.  For 1998, the company earned $1.67 per share.  Book value of $8.45 per share includes a mineral royalty interest in Canada that has a much higher market value.  MXBIF currently sells for less than 5X trailing earnings.

American Safety Razor (RAZR) was a short-term trading opportunity.  The price declined after a manufacturing facility was closed for a day due to a bomb scare.  There was a cash tender offer at the time, which provided an attractive return for a two week holding period.

Geltex Pharmaceuticals (GELX) was recently purchased for some accounts that are more risk-tolerant.  GELX develops polymer-based, non-absorbed pharmaceuticals that selectively bind and eliminate target substances from the intestinal tract.  Because the polymer-based drugs are not absorbed into the bloodstream, they do not have side effects on internal organs such as the liver.  The company introduced their first product, Renagel, in 1998 for the treatment of hyperphosphatemia, which affects 250,000 dialysis patients in the U.S.  GELX expects to file a new drug application this summer for Cholestagel.  Clinical trials have demonstrated Cholestagel's ability to reduce elevated cholesterol levels, a condition that affects 24 million Americans and another 26 million people in Europe.  Warburg Dillon Read estimates that GELX will earn $1.20 in 2001 and $2.34 per share in 2002.

^ back to top 

Deletions

The First Australia Income Fund (FAX) and Scudder International Bond Fund (SCIBX) were sold.  The discount to net asset value on FAX had declined as the price rose, so it was no longer as attractive as some other fixed income closed-end funds.  SCIBX was sold as the decline of the euro continued to reduce its net asset value.

Profits were taken on Telefonos de Mexico (TMX), Continental Airlines (CAL), and Atmel (ATML). All three have performed well but the valuations were no longer as compelling and I wanted to raise some cash due to the current high valuation level of the U.S. stock market.  Positions may be established in these companies again at a later date.

If you have any questions regarding your accounts, please do not hesitate to call me.

Sincerely,
Robert G. Kahl,
CFA, CPA, MBA

[back to Newsletter Archive]